Analyst consensus rating
Tiziana Life Sciences Analyst Rating: none
TLSA is rated none by 1 analysts with a $9.14 target. As of 2026-08-22.
Direct answer
Tiziana Life Sciences's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.14.
Forecast evidence checked August 22, 2026.
Get free Tiziana Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.14
- Average price target
- $9.14
- High price target
- $9.14
- Low price target
- $9.14
- Low target gap
- +701.5%
- Target upside
- +701.5%
- High target gap
- +701.5%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tiziana Life Sciences?
Tiziana Life Sciences has a verified none consensus. The same dataset has an average price target of $9.14.
How far are Tiziana Life Sciences's low and high targets from the recorded price?
The low target implies +701.5%, while the high target implies +701.5%.
How many analysts are included in Tiziana Life Sciences's consensus?
The verified consensus includes 1 analysts.
How is Tiziana Life Sciences's target upside or downside calculated?
The average target of $9.14 is divided by the recorded price of $1.14, then one is subtracted to produce +701.5%. This does not guarantee a future return.
When was Tiziana Life Sciences's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.